One day scientific conference hosted by Weqas consisting of Laboratory EQA interpretation, clinical cases and topical scientific lectures provided by Weqas staff and invited speakers.

TOPICS COVERED

• At the Weqas Annual Laboratory Conference 2025, delegates will engage in a comprehensive programme of presentations whereby they will gain valuable insights into key aspects of External Quality Assessment (EQA) and compliance.
• Morning sessions will provide participants the opportunity to develop the skills to interpret a range of EQA reports tailored for all laboratory personnel. Through interactive, case-based workshops, they will apply problem-solving tools to identify errors and propose remedial actions. Our Director will explain how laboratories can use Weqas EQA data to support 15189:2022 compliance.
• The conference will also include topical scientific presentations by invited speakers. Attendees will be provided with an opportunity to evaluate LDL measurement, weighing its advantages and disadvantages, explore challenges associated with FIT assays in symptomatic testing and discuss TBI markers and their potential implementation in laboratory settings. Furthermore, discussions will focus on evaluating the accuracy of calculated parameters and gaining a deeper understating of Measurement Traceability and Uncertainty.
• With a rich programme designed to enhance knowledge and practical expertise, this event promises to be an invaluable experience for laboratory professionals.

WHO SHOULD ATTEND?

The event is an education and training opportunity primarily aimed at Weqas EQA participants. Delegates typically include Biomedical Scientists, Laboratory Managers, Laboratory Technicians, Clinical Scientists, Training Officers, Quality Managers and Quality Officers.

SPEAKERS

• Gareth Davies (Weqas Deputy Director) and Samantha Jones (Weqas Operations Manager) – EQA Interpretation of Laboratory Results
• Gareth Davies (Weqas Deputy Director) and Samantha Jones (Weqas Operations Manager) – Case Studies Workshop
• David Ducroq (Head of Reference Laboratory) – Understanding Measurement Traceability and Uncertainty
• Annette Thomas (Weqas Director) and Gareth Davies (Weqas Deputy Director) – Getting the Best Out of Your EQA Data for ISO 15189:2022 Compliance
• Sally Benton (Consultant Biochemist/Hub Director) – Are Our FIT Assays Good Enough, and What Is the Symptomatic Threshold?
• Ceri Parfitt (R&D Clinical Scientist) – How Are We Ensuring the Accuracy of Our Calculated Parameters?
• Gordon Avery (Associate Scientific Director, Abbott) – TBI Markers – The New Kid(s) on the Block

For more information, please contact: [email protected].